Health CanadaGeneral Alert
LEMTRADA (alemtuzumab) - Risk of Autoimmune Hepatitis, Haemophagocytic Lymphohis...
Published: October 15, 2019Recall ID: 59746Category: generalCountry: Canada
Reason for Recall / Hazard
Product safety
Product Description & Identification
LEMTRADA (alemtuzumab) - Risk of Autoimmune Hepatitis, Haemophagocytic Lymphohistiocytosis, and Associated Serious Cardiovascular Reactions
Additional Source Details
| Field | Value |
|---|---|
| N I D | 59746 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/lemtrada-alemtuzumab-risk-autoimmune-hepatitis-haemophagocytic-lymphohistiocytosis-and |
| Issue | Product safety |
| Title | LEMTRADA (alemtuzumab) - Risk of Autoimmune Hepatitis, Haemophagocytic Lymphohistiocytosis, and Associated Serious Cardiovascular Reactions |
| Archived | 0 |
| Category | Drugs |
| Last updated | 2019-10-15 |
| Organization | Marketed health products |